CIK 0001434316 · Non-accelerated filer<br>Smaller reporting company
FATE THERAPEUTICS INC
Sign in to watch- Ticker
- FATE
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 651311552
- Phone
- 858.875.1803
- Business address
- 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
- 4 Planned sale Director sold 632 shares at $3.71 ($2,345)
- 4 Open-market sale Chief Commercial Officer sold 3,854 shares at $4.87 ($18,769)
- 4 Planned sale Chief Financial Officer sold 5,182 shares at $4.83 ($25,029)
- 4 Planned sale Director sold 3,460 shares at $5.58 ($19,307)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 276,639 shares at an average $6.17 ($1,705,829)
- 4 Planned sale Chief Medical Officer sold 2,532 shares at an average $6.57 ($16,648)
- 4 Open-market sale Director sold 302,339 shares at $5.84 ($1,765,660)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 21 · 403 filings